Cabaletta Bio Inc.
CABA | NASDAQ
$2.46
-$0.09 (-3.53%)
At close: Sep 21, 2026, 4:00 PM ET
$2.53
+$0.07 (+2.85%)
Pre-market:
Sep 22, 2026, 8:07 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -172.24M | -125.14M | -74.66M | -54.14M | -46.31M | -33.83M |
Interest Income | 6.03M | 10.03M | 6.99M | 1.16M | 24K | 494K |
Pretax Income | -167.86M | -115.86M | -67.68M | -52.98M | -46.29M | -33.34M |
Net Income | -167.86M | -115.86M | -67.68M | -52.98M | -46.29M | -33.34M |
Selling & General & Admin | 29.57M | 27.94M | 19.24M | 14.84M | 13.82M | 12.46M |
Research & Development | 142.67M | 97.2M | 55.42M | 39.3M | 32.49M | 21.38M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 172.24M | 125.14M | 74.66M | 54.14M | 46.31M | 33.83M |
Interest Expense | 2M | 748K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 172.24M | 125.14M | 74.66M | 54.14M | 46.31M | 33.83M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 102.26M | 49.52M | 40.95M | 29.34M | 25.74M | 23.15M |
Shares Outstanding (Diluted) | 102.26M | 49.47M | 40.95M | 29.34M | 25.74M | 23.15M |
EPS (Basic) | -1.64 | -2.34 | -1.65 | -1.81 | -1.80 | -1.44 |
EPS (Diluted) | -1.64 | -2.34 | -1.65 | -1.81 | -1.80 | -1.44 |
EBITDA | -164.21M | -113.41M | -66.25M | -51.8M | -45.56M | -32.99M |
EBIT | -165.85M | -115.12M | -67.68M | -52.98M | -46.29M | -33.34M |
Depreciation & Amortization | 1.65M | 1.71M | 1.43M | 1.18M | 733K | 354K |
Add to Watchlist
Select watchlists to add or remove CABA